X-12716641-G-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001368397.1(FRMPD4):​c.2182G>A​(p.Ala728Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,207,976 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 77 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A728V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000090 ( 0 hom., 4 hem., cov: 22)
Exomes 𝑓: 0.00021 ( 0 hom. 73 hem. )

Consequence

FRMPD4
NM_001368397.1 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.350

Publications

3 publications found
Variant links:
Genes affected
FRMPD4 (HGNC:29007): (FERM and PDZ domain containing 4) This gene encodes a multi-domain (WW, PDZ, FERM) containing protein. Through its interaction with other proteins (such as PSD-95), it functions as a positive regulator of dendritic spine morphogenesis and density, and is required for the maintenance of excitatory synaptic transmission. [provided by RefSeq, Jan 2010]
FRMPD4 Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, X-linked 104
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.026616186).
BP6
Variant X-12716641-G-A is Benign according to our data. Variant chrX-12716641-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 211050.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Hemizygotes in GnomAd4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRMPD4NM_001368397.1 linkc.2182G>A p.Ala728Thr missense_variant Exon 15 of 17 ENST00000675598.1 NP_001355326.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRMPD4ENST00000675598.1 linkc.2182G>A p.Ala728Thr missense_variant Exon 15 of 17 NM_001368397.1 ENSP00000502607.1 A0A6Q8PH73

Frequencies

GnomAD3 genomes
AF:
0.0000896
AC:
10
AN:
111659
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000151
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000927
AC:
17
AN:
183415
AF XY:
0.0000590
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000208
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000207
AC:
227
AN:
1096317
Hom.:
0
Cov.:
32
AF XY:
0.000202
AC XY:
73
AN XY:
361705
show subpopulations
African (AFR)
AF:
0.0000758
AC:
2
AN:
26383
American (AMR)
AF:
0.0000284
AC:
1
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19375
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54116
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40522
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4131
European-Non Finnish (NFE)
AF:
0.000258
AC:
217
AN:
840337
Other (OTH)
AF:
0.000130
AC:
6
AN:
46046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000896
AC:
10
AN:
111659
Hom.:
0
Cov.:
22
AF XY:
0.000118
AC XY:
4
AN XY:
33829
show subpopulations
African (AFR)
AF:
0.0000651
AC:
2
AN:
30714
American (AMR)
AF:
0.00
AC:
0
AN:
10570
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3553
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2635
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6019
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.000151
AC:
8
AN:
53096
Other (OTH)
AF:
0.00
AC:
0
AN:
1501
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000756
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000346
AC:
1
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 04, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Feb 28, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.025
DANN
Benign
0.88
DEOGEN2
Benign
0.022
T;T
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.82
T;T
M_CAP
Benign
0.0030
T
MetaRNN
Benign
0.027
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.0
L;.
PhyloP100
0.35
PrimateAI
Benign
0.29
T
PROVEAN
Benign
0.10
N;.
REVEL
Benign
0.014
Sift
Benign
0.54
T;.
Sift4G
Benign
0.39
T;T
Polyphen
0.0010
B;.
Vest4
0.10
MutPred
0.25
Gain of glycosylation at A728 (P = 0.0158);.;
MVP
0.10
MPC
0.12
ClinPred
0.052
T
GERP RS
-1.8
Varity_R
0.029
gMVP
0.17
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750615873; hg19: chrX-12734760; COSMIC: COSV66214605; COSMIC: COSV66214605; API